Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of
Vitamin C (ascorbic acid) intravenous infusion when used to treat alcoholic hepatitis
(inflammation of the liver from heavy alcohol use) and sepsis (life-threatening complication
of an infection).
Phase:
Phase 2
Details
Lead Sponsor:
Virginia Commonwealth University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)